ABSTRACT
To assess the health-related quality of life [HRQL] of patients with chronic obstructive pulmonary disease [COPD] in 4 Gulf Council Cooperation countries. We conducted a cross-sectional survey between December 2011 and March 2012 in the following countries: Kingdom of Saudi Arabia [Riyadh, Dammam, and Jeddah], Kuwait, Bahrain, and the United Arab Emirates. The HRQL was measured using the COPD Assessment Test [CAT] and the Chronic Respiratory Disease Questionnaire-Self-Administered Standardized questionnaire [CRQ-SAS]. We recruited 120 patients from 6 centers in 4 countries. Their average forced expiratory volume [FEV][1] was 49.3% [+/- 13.4] of predicted, and the ratio of FEV[1] to forced vital capacity was 0.58 [+/- 0.11]. The average COPD Assessment Test [CAT] score was 20.4 +/- 7.6; CAT scores were highest for Riyadh [24.1 +/- 7.7]; and lowest for Kuwait [18.5 +/- 9.2], with no significant difference between the centers. For the CRQ-SAS, the dyspnea domain score was 4.6 +/- 1.6, the fatigue domain score was 4.3 +/- 1.3, the emotional domain was 4.6 +/- 1.2, and the mastery domain was 4.8 +/- 1.4. The correlation coefficients of the association between the CAT score and the 4 domains of the CRQ-SAS for all of the centers combined was statistically significant. The CAT and CRQ-SAS revealed that the patients with COPD experienced a moderate to severe impact from the disease, and a considerably compromised quality of life in the GCC countries
ABSTRACT
To review a general hospital's experience with sarcoidosis and the clinical pattern of the disease among Saudis. A retrospective file review was carried out on all patients with a proven diagnosis of sarcoidosis in a general hospital in Eastern Saudi Arabia over a period of 11 years [1998-2008]. Sixty-nine patients, of whom 33 cases were included in the analyses, were diagnosed to have sarcoidosis during the study period. There were 18 females and 15 males. The mean age was 44.5 years [SD 17]. The most common presentations were cough [48%], dyspnea [21%], joint pain [18%], splenomegaly [12%], hepatomegaly [9%], and lymphadenopathy [5%]. The biochemical analysis showed elevated calcium levels in 6% and elevated angiotensin converting enzyme [ACE] in 14 [46.7%]. The tuberculin skin test was negative in all tested patients [n = 29] except one patient. The patients were classified using the modified Scadding classification system. None of the patients was in stage 0, 39.4% were in stage 1, 45% were in stage 2 and 15% were in stage 3.. The diagnosis in all patients was proven histologically. The outcome was favorable in most patients [85%], and in 6% of the patients, the course was chronic and progressive, although 66% received active treatment. Sarcoidosis does occur in native Saudis. The clinical presentation of these patients was similar to the western pattern of disease with some differences such as relative lack of cardiac, eye, parotid, and central nervous system involvement. The rarity of cardiac and central nervous system involvement was comparable with other Middle Eastern studies. Sarcoidosis, though rare in our community, should still be considered in the differential diagnosis of patients with the typical presentation after excluding tuberculosis